Advertisement

Cerner lands FDA clearance for its Cerner FetaLink+, a mobile maternal and fetal monitoring device that could help clinicians provide high level of care for patients.

Cerner logo

Kansas City, Mo.-based healthcare provider Cerner (NSDQ:CERN) received FDA clearance to market its mobile maternal and fetal monitoring system, called Cerner FetaLink+, a device that help clinicians monitor mothers and babies using iPads or iPhones.

The newly approved Cerner FetaLink+, which integrates with Cerner's PowerChart Touch iPad app, provides near real-time access to critical information about the status of patients and waveform data over time, according to the press release. 

Advertisement
Advertisement